Celularity Inc
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -375.3% | -219.8% | -219.8% | -30.0% | -35.8% | -1.5% | 8.8% | 8.8% | -17.4% | -78.7% | -124.3% | -124.3% | -79.9% | |
| 152.2% | 61.9% | 61.9% | 14.7% | 19.0% | 20.4% | 10.3% | 10.3% | 32.0% | 34.5% | 43.9% | 43.9% | 37.8% | |
| 131.2% | 95.0% | 95.0% | 20.2% | 29.5% | 28.7% | 17.1% | 17.1% | 42.7% | 38.6% | 79.2% | 79.2% | 57.2% | |
| 946.1% | – | – | – | – | – | – | – | – | – | – | – | – | |
| 40.7% | 48.0% | 5.7% | -14.4% | -273.2% | 93.8% | 53.8% | 53.8% | 257.3% | 126.6% | 191.6% | 191.6% | 193.3% | |
| 1.1% | 6.0% | 6.0% | 0.3% | 4.8% | 0.4% | 0.3% | 0.3% | 0.0% | 1.1% | 0.0% | 0.0% | 0.3% | |
| -1.1% | – | -6.0% | – | -4.8% | -0.4% | – | -8.6% | – | 54.7% | – | – | – | |
| 1.1% | – | – | – | – | – | – | – | – | 1.2% | 0.0% | – | – | |
| -1.1% | – | 0.0% | – | -0.1% | – | – | – | – | – | – | – | – | |
| -95.9% | – | – | – | – | -0.1% | 3.2% | -0.2% | -0.6% | 128.2% | -166.2% | – | – | |
| 190.9% | 151.6% | 151.6% | 42.4% | -0.1% | -0.8% | 3.5% | 3.5% | 28.4% | 65.8% | 273.4% | 273.4% | 143.3% | |
| -185.4% | -74.2% | -74.2% | 12.2% | -40.7% | -2.8% | 3.8% | 3.8% | 9.9% | -14.1% | 149.0% | 149.0% | 62.7% | |
| -376.4% | -225.8% | -225.8% | -30.3% | -40.6% | -1.9% | 8.5% | 8.5% | -17.4% | -78.7% | -124.3% | -124.3% | -79.9% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.